论文部分内容阅读
Ventricular assist devices have become accepted therapy for treatment of acute cardiogenic shock, decompensated and end-stage heart failure.Current generation of devices is superior to the first generation of ventricular assist devices and is being used routinely and with improved outcomes versus optimal medical therapy.